FI47352C - Menetelmä tulehdusta ehkäisevien 6alfa-fluori-2-kloori-16alfa-metyyli- 1,4-pregnadieeni-3,20-dionijohdannaisten valmistamiseksi. - Google Patents
Menetelmä tulehdusta ehkäisevien 6alfa-fluori-2-kloori-16alfa-metyyli- 1,4-pregnadieeni-3,20-dionijohdannaisten valmistamiseksi.Info
- Publication number
- FI47352C FI47352C FI701147A FI114770A FI47352C FI 47352 C FI47352 C FI 47352C FI 701147 A FI701147 A FI 701147A FI 114770 A FI114770 A FI 114770A FI 47352 C FI47352 C FI 47352C
- Authority
- FI
- Finland
- Prior art keywords
- 6alpha
- 16alpha
- pregnadiene
- fluoro
- inflammatory
- Prior art date
Links
- TXUSTEBONRLLCL-OWGDEBHYSA-N C[C@@H]1C[C@H]2[C@@H]3C[C@@H](C4=CC(=O)C(=C[C@@]4([C@H]3CC[C@@]2([C@H]1C(=O)C)C)C)Cl)F Chemical class C[C@@H]1C[C@H]2[C@@H]3C[C@@H](C4=CC(=O)C(=C[C@@]4([C@H]3CC[C@@]2([C@H]1C(=O)C)C)C)Cl)F TXUSTEBONRLLCL-OWGDEBHYSA-N 0.000 title 1
- 230000003110 anti-inflammatory effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A47—FURNITURE; DOMESTIC ARTICLES OR APPLIANCES; COFFEE MILLS; SPICE MILLS; SUCTION CLEANERS IN GENERAL
- A47G—HOUSEHOLD OR TABLE EQUIPMENT
- A47G19/00—Table service
- A47G19/22—Drinking vessels or saucers used for table service
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
-
- E—FIXED CONSTRUCTIONS
- E21—EARTH OR ROCK DRILLING; MINING
- E21D—SHAFTS; TUNNELS; GALLERIES; LARGE UNDERGROUND CHAMBERS
- E21D23/00—Mine roof supports for step- by- step movement, e.g. in combination with provisions for shifting of conveyors, mining machines, or guides therefor
- E21D23/04—Structural features of the supporting construction, e.g. linking members between adjacent frames or sets of props; Means for counteracting lateral sliding on inclined floor
- E21D23/06—Special mine caps or special tops of pit-props for permitting step-by-step movement
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Mining & Mineral Resources (AREA)
- Geochemistry & Mineralogy (AREA)
- Architecture (AREA)
- Structural Engineering (AREA)
- General Life Sciences & Earth Sciences (AREA)
- Geology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Steroid Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19691921398 DE1921398C3 (de) | 1969-04-23 | 1969-04-23 | 2-Chlor-3-oxo-l,4-pregnadiene, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel |
DE19691921397 DE1921397C3 (de) | 1969-04-23 | 1969-04-23 | 2-Chlor und 1,2-Dichlorsteroide, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel |
DE19691931508 DE1931508C3 (de) | 1969-06-19 | 1969-06-19 | Neue 2-Chlorsteroide und Verfahren zu ihrer Herstellung |
Publications (2)
Publication Number | Publication Date |
---|---|
FI47352B FI47352B (fi) | 1973-07-31 |
FI47352C true FI47352C (fi) | 1973-11-12 |
Family
ID=27181910
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI701147A FI47352C (fi) | 1969-04-23 | 1970-04-23 | Menetelmä tulehdusta ehkäisevien 6alfa-fluori-2-kloori-16alfa-metyyli- 1,4-pregnadieeni-3,20-dionijohdannaisten valmistamiseksi. |
Country Status (12)
Country | Link |
---|---|
US (1) | US3678034A (fi) |
JP (1) | JPS5441589B1 (fi) |
CH (4) | CH543495A (fi) |
DK (1) | DK131787C (fi) |
ES (1) | ES378932A1 (fi) |
FI (1) | FI47352C (fi) |
FR (1) | FR2042366B1 (fi) |
GB (1) | GB1316663A (fi) |
IE (1) | IE34111B1 (fi) |
IL (1) | IL34347A (fi) |
NL (1) | NL170007C (fi) |
NO (1) | NO131128C (fi) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4221786A (en) * | 1978-06-20 | 1980-09-09 | Ciba-Geigy Corporation | Novel halogenopregnadienes and process for the manufacture thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3232835A (en) * | 1957-12-04 | 1966-02-01 | Pfizer & Co C | 2-chloro prednisones and the 9alpha-fluoro derivatives thereof |
-
1970
- 1970-04-17 CH CH243673A patent/CH543495A/de not_active IP Right Cessation
- 1970-04-17 CH CH243873A patent/CH547273A/xx not_active IP Right Cessation
- 1970-04-17 CH CH578970A patent/CH546750A/xx not_active IP Right Cessation
- 1970-04-17 CH CH243773A patent/CH547272A/xx not_active IP Right Cessation
- 1970-04-19 IL IL34347A patent/IL34347A/en unknown
- 1970-04-21 IE IE513/70A patent/IE34111B1/xx unknown
- 1970-04-22 NO NO1538/70A patent/NO131128C/no unknown
- 1970-04-22 DK DK203270A patent/DK131787C/da active
- 1970-04-22 ES ES378932A patent/ES378932A1/es not_active Expired
- 1970-04-22 US US30934A patent/US3678034A/en not_active Expired - Lifetime
- 1970-04-23 NL NLAANVRAGE7005955,A patent/NL170007C/xx not_active IP Right Cessation
- 1970-04-23 GB GB1954370A patent/GB1316663A/en not_active Expired
- 1970-04-23 FR FR7014798A patent/FR2042366B1/fr not_active Expired
- 1970-04-23 FI FI701147A patent/FI47352C/fi active
- 1970-04-23 JP JP3507170A patent/JPS5441589B1/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
ES378932A1 (es) | 1972-08-01 |
NO131128C (fi) | 1975-04-09 |
IL34347A0 (en) | 1970-06-17 |
US3678034A (en) | 1972-07-18 |
DK131787B (da) | 1975-09-01 |
NL7005955A (fi) | 1970-10-27 |
FR2042366B1 (fi) | 1974-04-12 |
IL34347A (en) | 1973-10-25 |
CH546750A (de) | 1974-03-15 |
FI47352B (fi) | 1973-07-31 |
IE34111B1 (en) | 1975-02-05 |
NO131128B (fi) | 1974-12-30 |
JPS5441589B1 (fi) | 1979-12-08 |
DK131787C (da) | 1976-02-02 |
IE34111L (en) | 1970-10-23 |
CH543495A (de) | 1973-10-31 |
CH547272A (de) | 1974-03-29 |
GB1316663A (en) | 1973-05-09 |
FR2042366A1 (fi) | 1971-02-12 |
CH547273A (de) | 1974-03-29 |
NL170007C (nl) | 1982-09-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI49302C (fi) | Menetelmä sepelvaltimoa laajentavien N6-bentsyyli-adenosiini-johdannai sten valmistamiseksi. | |
DK129988B (da) | Fremgangsmåde til fremstilling af 17-monoestere af 17α,21-dihydroxy-20-keto-steroidforbindelser af pregnanrækken. | |
FI47572C (fi) | Menetelmä 19-norandrost-4-eeni-3,17-dionien valmistamiseksi. | |
FI45444C (fi) | Menetelmä tulehdusta estävien 6alfa-fluori-9alfa,11beta-dihalogeeni-16 alfa-metyyli-1,4-pregnadieeni-3,20-dionijohdannaisten valmistamiseksi | |
FI47575C (fi) | Analogiamenetelmä evomonosidi-johdannaisten valmistamiseksi. | |
DK128352B (da) | Analogifremgangsmåde til fremstilling af 9α-fluor-11β-hydroxypregna-1,4-dien-3,20-dion-[17α,16α-d]-oxazolidinoxaziner. | |
FI46619C (fi) | Menetelmä steroidi-johdannaisten 17alfa,21-ortokarbonaattien valmistam iseksi. | |
DK128895B (da) | Fremgangsmåde til fremstilling af pregnanderivater. | |
FI47352C (fi) | Menetelmä tulehdusta ehkäisevien 6alfa-fluori-2-kloori-16alfa-metyyli- 1,4-pregnadieeni-3,20-dionijohdannaisten valmistamiseksi. | |
FI46952C (fi) | Menetelmä 6alfa-fluori-9alfa,11beta,21-trihalogeeni-1,4-pregnadieeni-3 ,20-dioni-johdannaisten valmistamiseksi | |
FI49159C (fi) | Menetelmä 9alfa-halogeeni-6alfa,16alfa-dimetyyli-1,4-pregnadieeni-3,20 -dioni-johdannaisten valmistamiseksi. | |
FI49160C (fi) | Menetelmä 6alfa-fluori-16alfa,18-dimetyyli-1,4-pregnadien-3,20-dionijo hdannaisten valmistamiseksi. | |
DK130957B (da) | Fremgangsmåde til fremstilling af pregnanderivater. | |
FI52577C (fi) | Menetelmä terapeuttisesti käytettävien fenatsiinijohdannaisten valmist amiseksi. | |
FI47763C (fi) | Menetelmä uusien neriifoliini-johdannaisten valmistamiseksi. | |
FI48347C (fi) | Menetelmä 17beta-alkanoyylioksi-17alfa-propadienyyli-steroidien valmis tamiseksi. | |
FI46727C (fi) | Menetelmä pyridatsolijohdannaisten valmistamiseksi. | |
FI47481C (fi) | Analogiamenetelmä uusien tulehdusta estävästi ja gestageenisesti vaiku ttavien 21-fluori-6-halogeeni-16,17-dihydroksi-pregna-4,6-dieeni-3,20- dionijohdannaisten valmistamiseksi. | |
FI46845C (fi) | Menetelmä 6alfa-fluori-21-halogeeni-11beta-hydroksi-16alfa-metyyli-1,4 -pregnadieeni-3,20-dioni-johdannaisten valmistamiseksi. | |
FI45552C (fi) | Menetelmä 17alfa-asyylioksi-11beta-metyyli-19-norpregn-4-eeni-3,20-dio nien ja niiden johdannaisten valmistamiseksi. | |
DK124539B (da) | Fremgangsmåde til fremstilling af 6-hydroxy-3-keto-Δ<1,4>-steroider af pregnan- eller androstanrækken. | |
FI52088C (fi) | Menetelmä 3-(4-asyylioksialkyyli-1-piperatsinyyli)-karbonyylimetyyli-2 -bentsotiatsolinonijohdannaisten valmistamiseksi. | |
FI49162C (fi) | Menetelmä terapeuttisesti käytettävien 3-indolyyli-alifaattinen-happo- johdannaisten valmistamiseksi. | |
DK120487B (da) | Fremgangsmåde til fremstilling af ætynylderivater af oxosteroider af pregnan-, østran- eller androstanrækken. | |
DK126937B (da) | Fremgangsmåde til fremstilling af 4,6-dihalogen-16-alkyliden-17α-hydroxy-pregna-4,6-dien-3,20-dioner. |